TFX Teleflex Incorporated
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.…
Industry Peers
Medical Instruments & SuppliesKey Statistics
About Teleflex (NYSE: TFX)
›
Teleflex (NYSE: TFX) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 15,500 employees.
The shares were at 163.40 USD on 19 November 2026, up 53.5% over 52 weeks. Its 52-week range is 100.18 USD to 166.75 USD: the price is 2.0% below the high and 63.1% above the low.
At a market capitalisation of 6.48B USD, it trades at 80.5 times trailing earnings and 14.9 times forward earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 49.2, a premium of 63% for TFX. It pays a dividend yielding 0.82% (it pays out 67% of its earnings), against a median of 0.93% among the dividend payers in that peer group.
Teleflex reports return on equity of -29.0%, an operating margin of 11.7% and flat revenue year over year.
Its debt exceeds its cash by 1.26B USD, a debt-to-equity ratio of 0.87. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 11 analysts cover the stock, with an average rating of Buy; their mean price target of 168.09 USD is 2.9% above the current price. The next earnings report is expected on 25 February 2027.